Profiel
Karen Eaton was the founder of Sigma Genetics, Inc. (founded in 2016) where she held the title of Chief Executive Officer from 2016 to 2017.
She is currently working as a Venture Partner at Pioneer Fund since 2022.
Ms. Eaton has an MBA and a doctorate from the University of Washington.
Actieve functies van Karen Eaton
| Bedrijven | Functie | Begin |
|---|---|---|
Pioneer Fund/NY/
Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund invests in companies located across the globe. The firm targets companies operating in the fields of biotechnology, healthcare and life sciences sectors. It provides financing for seed and early stage capital requirements. | Private Equity Investor | 01-01-2022 |
Eerdere bekende functies van Karen Eaton
| Bedrijven | Functie | Einde |
|---|---|---|
Sigma Genetics, Inc.
Sigma Genetics, Inc. Medical SpecialtiesHealth Technology Manufactures non-invasive devices | Algemeen Directeur | 01-10-2017 |
Opleiding van Karen Eaton
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pioneer Fund/NY/
Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund invests in companies located across the globe. The firm targets companies operating in the fields of biotechnology, healthcare and life sciences sectors. It provides financing for seed and early stage capital requirements. | Finance |
Sigma Genetics, Inc.
Sigma Genetics, Inc. Medical SpecialtiesHealth Technology Manufactures non-invasive devices | Health Technology |
















